After treatment is initiated, weekly to bi-weekly follow-up visits are needed to monitor adverse effects and symptom change and response. Ongoing assessment of functioning in several key domains is required (home, school, and peer settings), as well as assessments of suicidality. If a child makes good progress and the treatment is an appropriate choice for the child, the visit frequency may be reduced to once every 4 to 6 weeks during the continuation phase of treatment. Despite guidelines recommending regular follow-up care, the majority of youth being treated with antidepressants do not receive adequate follow-up care. Monitoring during the continuation phase of treatment is also important, as the relapse rate is high. Compliance becomes a bigger issue during the continuation phase of treatment. Having a good relationship with patients and their families may improve adherence.
Use of this content is subject to our disclaimer